This fund offers capital grants to UK private sector life sciences companies for large-scale R&D projects exceeding £100 million. It supports innovation in human medicines, medical diagnostics, and MedTech, aiming to strengthen health resilience and generate economic benefits. Grants typically cover 10-20% of project costs, focusing on projects dependent on funding to proceed. The application involves eligibility screening, innovation assessment, and financial due diligence.
Eligible applicants are UK-registered, wholly private sector companies operating as product developers, CDMOs, or generics manufacturers with a track record in medicines or medical devices. Projects must be UK-based, single-company, capital-intensive, and dependent on the grant to proceed.
